Home drug
 

Keywords :   


Tag: drug

Merck Announces U.S. FDA Filing Acceptance of New Drug Application (NDA) for MK-1293, an Investigational Follow-On Biologic Insulin Glargine

2016-08-05 14:00:00| Merck.com - Research & Development News

Dateline City: KENILWORTH, N.J. Marketing Authorization Application to the European Medicines Agency Currently Under Review KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for MK-1293, an investigational follow-on biologic1 insulin glargine candidate for the treatment of people with type 1 and type 2 diabetes, which is being developed by Merck with partial funding from Samsung Bioepis. Language: English Contact: MerckMedia:Doris Li, 908-246-5701orKristen Drake, 908-236-4223orInvestors:Amy Klug, 908-740-1898 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: application drug acceptance filing

 

05/04/12 -- Oral Fluid Drug Test Includes Four Drugs To Address Changing Abuse

2016-06-13 18:59:24| drugdiscoveryonline News Articles

05/04/12 Drug Discovery Online Newsletter

Tags: address includes test abuse

 
 

06.01.12 -- FDA-Approved Drug Makes Established Cancer Vaccine Work Better

2016-06-13 18:59:24| drugdiscoveryonline News Articles

06/01/12 Drug Discovery Online Newsletter

Tags: work better makes established

 

The Challenges Of Demand Forecast Accuracy For New Drug Launches

2016-06-13 11:39:02| drugdiscoveryonline Downloads

This webinar discusses how achievingaccurate demand forecasts is extremely challenging, especially for new drug launches, and what other pharmaceutical companies are doing to overcome those challenges.

Tags: drug accuracy demand challenges

 

Impact Of Incorrect Forecasts On New Drug Product Launches

2016-06-10 17:34:44| drugdiscoveryonline Home Page

Pharmaceutical companies around the world are under tremendous pressure – from regulators, legislators, payers, and patients – to reduce the cost of drugs. In response to the outcry for cost-cutting, pharmaceutical company leaders are examining every aspect of their business to determine where they can derive savings, particularly when planning for the launch of a new product. Pharmaceutical company marketing executives have become more accurate in positioning their new product in the marketplace, profiling prescribers, and understanding and responding to the reimbursement landscape. What is still a quagmire for pharma companies is predicting the actual demand for products and the timing of that demand.

Tags: product impact drug incorrect

 

Sites : [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] next »